Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the effect of VX-509 on the pharmacokinetics (PK) of
corticosteroids (prednisone or methylprednisolone) and the effect of corticosteroids on the
PK of VX-509 and its metabolite. The study will also evaluate the safety and tolerability of
VX-509 when coadministered with each of these corticosteroids.